MoleSense
About
What does MoleSense do?
MoleSense is developing an AI-driven platform designed to assist individuals and healthcare professionals in the early detection and ongoing monitoring of skin conditions, with a primary focus on melanoma. The technology aims to provide accessible and accurate analysis of skin lesions through user-friendly interfaces.
What is MoleSense's revenue?
StartupHub estimates MoleSense's annual revenue at $1.1M (range $382K to $1.6M, 28% confidence), based on comparable companies in the sector.
What is MoleSense's valuation?
StartupHub estimates MoleSense's effective valuation at $6.0M (range $4.2M to $10.0M, 20% confidence), based on comparable companies in the sector.
How much funding has MoleSense raised?
MoleSense has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
Where is MoleSense headquartered?
MoleSense is headquartered in Tel Aviv, Israel.
When was MoleSense founded?
MoleSense was founded in 2021.
What industry does MoleSense operate in?
MoleSense operates in HealthTech, MedTech, AI-Driven Drug Discovery, Computer Vision, Digital Twin Healthcare, Consumer App.
What is MoleSense's current status?
MoleSense's current operating status is: Inactive.
No comments yet. Be the first to share your take.